Cerebral Palsy (CP) is a heterogeneous group of conditions that cause non-progressive childhood disabilities, characterized by varying degrees of motor and intellectual dysfunction. To date, no fully restorative treatment for CP has been developed, however, a few clinical trials conducted in the past have implicated the potential benefit of Mesenchymal Stem Cell (MSC) therapy for the patients with CP.
No takes yet. Share an insight, caveat, or question.
Ridhima et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: